The people
What they build
Open roles via the TechTO Job Board
Working at Pivotal Life Sciences
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Pivotal Life Sciences’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: pivotallifesciences.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
About
Pivotal Life Sciences describes itself as "an investment platform that specializes in providing capital to innovative companies developing therapeutic products and technologies to address major unmet medical needs." The screen it applies is a high one: it looks for therapies with "near-curative or otherwise transformative disease management potential" rather than marginal improvements on existing standards of care.
The platform runs three strategies rather than a single fund. Pivotal bioVenture Partners invests in private therapeutics companies in North America and Europe; a China arm does the same in that market; and Pivotal Public Equity invests in listed life sciences companies. Working across private and public markets in one house is deliberate — the same scientific judgement is applied whether a company is years from a trial readout or already trading on it.
It operates from four offices: San Francisco, Boston, Shanghai and Hong Kong. Shiva Amiri, who spoke at TechTO in 2017 as CEO of the biomedical machine-learning company BioSymetrics, is a partner there and heads AI and data intelligence — building the data science function inside an investor rather than a portfolio company.
Backers
Trade databases describe Pivotal Life Sciences as backed by Hong Kong's Nan Fung Group. The firm's own about page names no parent or limited partners and publishes no assets-under-management figure, so the relationship is recorded here as reported rather than confirmed.
Quick answers
What does Pivotal Life Sciences invest in?
Therapeutics companies addressing major unmet medical needs, with a stated preference for treatments that are near-curative or otherwise transformative rather than incremental. It invests in both private companies and listed ones.
How is it structured?
Three arms: Pivotal bioVenture Partners for private investing in North America and Europe, a separate China venture arm, and Pivotal Public Equity for public markets.
Where is it based?
San Francisco, with further offices in Boston, Shanghai and Hong Kong.
What is the TechTO connection?
Shiva Amiri is a partner and heads AI and data intelligence. She spoke at TechTO in 2017 as CEO of BioSymetrics, the biomedical machine-learning company, and earlier led informatics at the Ontario Brain Institute.